Enhertu Beats Chemotherapy for HER2-Low and -Ultralow Metastatic Breast Cancer
moderators
Posts: 9,647
Enhertu Beats Chemotherapy for HER2-Low and -Ultralow Metastatic Breast Cancer
Jun 17, 2024
Enhertu offers better survival than chemotherapy for pre-treated, metastatic, HER2-low or -ultralow breast cancer. Read more…
Tagged:
0
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your NEW profile.